Recent Articles

Results From CBD Clinical Trial to Assess Efficacy on Seizure Frequency in Dogs ‘Encouraging’

May 14, 2020

Promising, and exciting. Those are the words used by Dr. Stephanie McGrath to describe new findings from a trailblazing pilot study to assess the use of cannabidiol, or CBD, for dogs with epilepsy. McGrath, a neurologist at Colorado State University’s James L. Voss Veterinary Teaching Hospital, led a small study with 16 pet dogs to assess…

Clinical Trials Commence for CBD Pet Products

May 14, 2020

Products using hemp-derived cannabidiol (CBD) designed for pets is not a new concept; Companies have been marketing CBD pet products for quite some time now, making their way into pet stores across the United States. Some pet owners have embraced the trend, using CBD oil to calm pets down, help alleviate joint pain as well…

Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs

May 14, 2020

Objectives: The objectives of this study were to determine basic oral pharmacokinetics, and assess safety and analgesic efficacy of a cannabidiol (CBD) based oil in dogs with osteoarthritis (OA). Methods: Single-dose pharmacokinetics was performed using two different doses of CBD enriched (2 and 8 mg/kg) oil. Thereafter, a randomized placebo-controlled, veterinarian, and owner blinded, cross-over study was…